Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent T Ho

Showing results (121-130 of 227) with videos related to

Pageof 23
Sort By:
Transplantation and Cellular Therapy|June 14, 2021
Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell TransplantationYoshihiro Inamoto, Paul J Martin, Lynn E Onstad, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Haematologica|August 26, 2021
Allogeneic hematopoietic cell transplantation outcomes in patients with Richter's transformationHaesook T Kim, Peter O Baker, Erin Parry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2011
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor graftsYi-Bin Chen, Julie Aldridge, Haesook T Kim, et al.
Blood Advances|February 9, 2021
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experienceKatie Maurer, Anna Saucier, Haesook T Kim, et al.
Blood|June 20, 2012
A disease risk index for patients undergoing allogeneic stem cell transplantationPhilippe Armand, Christopher J Gibson, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemiaYi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
Angiogenic cytokines are antibody targets during graft-versus-leukemia reactionsMatthias Piesche, Vincent T Ho, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2010
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantationPhilippe Armand, Haesook T Kim, Joanna Rhodes, et al.
Blood|July 18, 2013
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trialCorey Cutler, Haesook T Kim, Bhavjot Bindra, et al.
Pageof 23

Showing results (121-130 of 227) with videos related to

Sort By:
Pageof 23
Transplantation and Cellular Therapy|June 14, 2021
Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell TransplantationYoshihiro Inamoto, Paul J Martin, Lynn E Onstad, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Haematologica|August 26, 2021
Allogeneic hematopoietic cell transplantation outcomes in patients with Richter's transformationHaesook T Kim, Peter O Baker, Erin Parry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2011
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor graftsYi-Bin Chen, Julie Aldridge, Haesook T Kim, et al.
Blood Advances|February 9, 2021
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experienceKatie Maurer, Anna Saucier, Haesook T Kim, et al.
Blood|June 20, 2012
A disease risk index for patients undergoing allogeneic stem cell transplantationPhilippe Armand, Christopher J Gibson, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemiaYi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
Angiogenic cytokines are antibody targets during graft-versus-leukemia reactionsMatthias Piesche, Vincent T Ho, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2010
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantationPhilippe Armand, Haesook T Kim, Joanna Rhodes, et al.
Blood|July 18, 2013
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trialCorey Cutler, Haesook T Kim, Bhavjot Bindra, et al.
Pageof 23